Interferon-γ protects against herpes simplex virus type 1-mediated neuronal death

Virology

Volumn 238, Issue 2, 1997, Pages 189-197

  Geiger, Kathrin D ^a   Nash, Therese C ^a   Sawyer, Stephen ^a   Krahl, Troy ^a   Patstone, Gail ^a   Reed, John C ^b   Krajewski, Stan ^b   Dalton, Dyana ^c   Buchmeier, Michael J ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIGENIN; DNA FRAGMENT; GAMMA INTERFERON; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; KNOCKOUT MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE;

EID: 0031585558     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8841     Document Type: Article

References (70)

1. Abe-Domae S., Harada N., Yamada K., Tanaka R. Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochem. Biophys. Res. Commun. 191:1993;915-921.
2. Akbar A. N., Salmon M., Janossy G. Role of bcl-2 and apoptosis in viral infections. Int. Arch. Allergy Immunol. 105:1994;359-362.
3. Allsopp T. E., Wyatt S., Paterson H. F., Davies A. M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1993;295-307.
4. Behl C., Hovey L., Krajewski S., Schubert D., Reed J. C. Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Commun. 197:1993;949-956.
5. Boise L. H., Gonzalea-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X. et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
6. Borysiewicz L. K., Sisson J. G. P. Cytotoxic T cells and human herpes virus infections. Curr. Top. Microbiol. Immunol. 189:1994;123-150.
7. Bouley D. M., Kanagat S., Wire W., Rouse B. T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:1995;3964-3971.
8. Bredesen D. E. Neural apoptosis. Ann. Neurol. 38:1995;839-851.
9. Butz E. A., Hostager B. S., Southern P. J. Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis. Microb. Pathol. 16:1994;283-295.
10. Cantin E. M., Hinton D. R., Chen J., Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:1995;4898-4905.
11. Chao C. C., Hu S., Sheng W. S., Bu D., Bukrinsky M. I. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
12. Chou J., Roizman B. The γ1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death. Proc. Natl. Acad. Sci. USA. 89:1992;3266-3207.
13. Colotta F., Re F., Polentaruttti N., Sozzani S., Montovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 80:1992;2012-2020.
14. Cooper P. D. The plaque assay of animal viruses. Methods in Virology. 1967;Academic Press, New York. p. 243-311.
15. Croen K. D. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:1993;2446-2452.
16. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science. 259:1993;1739-1742.
17. Davies A. M. The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci. 18:1995;355-358.
18. Di Fabio S., Mbawuike I. N., Kiyono H., Fujihashi K., Couch R. B., McGhee J. R. Quantitation of human influenza virus specific cytotoxic T lymphocytes: Correlation of cytotoxicity and increased numbers of IFN-γ producing CD8+ cells. Int. Immunol. 6:1994;11-19.
19. Frankowski H., Missotten M., Fernabdez P. A., Martinou I., Michel P., Sadoul R., Martinou J. C. Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport. 6:1995;1917-1921.
20. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
21. Geiger K., Howes E., Gallina M., Huang X. J., Travis G. H., Sarvetnick N. Transgenic mice expressing IFN-γ in the retina develop inflammation and photoreceptor loss. Invest. Ophthalmol. Vis. Sci. 35:1994a;2667-2681.
22. Geiger K., Howes E. L., Sarvetnick N. Ectopic expression of IFN-γ in the eye protects transgenic mice from intraocular HSV-1 infections. J. Virol. 69:1994b;5556-5567.
23. Geiger K. D., Gurushantayah D., Howes E. L., Lewandowski G. A., Bloom F. E., Reed J. C., Sarvetnick N. E. Cytokine mediated survival from lethal HSV-infection: Role of programmed cell death. Proc. Natl. Acad. Sci. USA. 92:1995;3411-3415.
24. Goureau O., Lepoivre M., Courtois Y. Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retinal pigmented epithelial cells. Biochem. Biophys. Res. Commun. 186:1992;854-859.
25. Graziosi C., Pantaleo G., Gantt K. R., Fortin J. P., Demarest J. F., Cohen O. J., Sekaly P. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science. 265:1994;248-252.
26. Griffin D. E., Levine B., Tyor W. R., Tucker P. C., Hardwick J. M. Age-dependent susceptibility to fatal encephalitis: Alphavirus infection of neurons. Arch. Virol. Suppl. 9:1994;31-39.
27. Hanada M., Krajewski S., Tanaka S., Cazal-Hatem D., Spengler B. A., Ross R. A., Biedler J. L. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53:1993;4978-4986.
28. Heise M. T., Virgin H. W. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:1995;904-909.
29. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107-1115.
30. Hendricks R. L., Tumpey T. M., Finnegan A. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149:1992;3023-3028.
31. Ho A. D., Moritz T., Rensch K., Hunstein W., Kirchner H. Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphoma. J. IFN Res. 8:1988;405-413.
32. Jackson A. C., Rositer J. P. Apoptosis plays an important role in experimental rabies virus infection. J. Virol. 71:1997;5603-5607.
33. Karupiah G., Xie Q. W., Buller R. M., Nathan C., Duarte C., MacMicking J. D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 261:1993;1445-1448.
34. Krajewski S., Krajewska M., Shabik A., Miyashita T., Wang H., Reed J. C. Immunohistochemical determination ofin vivo. Am. J. Pathol. 145:1994a;1323-1336.
35. Krajewski S., Krajewska M., Shabik A., Qang H. G. W., Irie S., Fong L., Reed J. C. Immunohistochemical analysis of in vivo patterns of Bcl-x. Cancer Res. 54:1994b;5501-5507.
36. Ksander B. R., Streilein J. W. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors. Invest. Ophthalmol. Vis. Sci. 30:1989;323-329.
37. Ksander B. R., Streilein J. W. Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites. J. Immunol. 145:1990;2057-2063.
38. Lee S. C., Dickson D. W., Liu W., Brosnan C. F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46:1993;19-24.
39. Lewis J., Wesselingh S. L., Griffin D. E., Hardwick J. M. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70:1996;1828-1835.
40. Lotem J., Sachs L. Interferon-gamma inhibits apoptosis induced by wild type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells. Leukemia. 9:1995;685-692.
41. Lucchiari M. A., Pereira C. A. A major role of macrophage activation by interferon-gamma during mouse hepatitis virus type 3 infection. II. Age-dependent resistance. Immunobiology. 181:1990;31-39.
42. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
43. Messmer U. K., Ancarcrona M., Nicotera P., Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355:1994;23-26.
44. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H., Liebermann D. A., Hoffman B. et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
45. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
46. Motoyama N. W. F., Roth F. A., Sawa H., Nakayama K. I., Nakayama K., Negishi I. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1995;1506-1509.
47. Mueller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
48. Niemialtowski M. G., Rouse B. T. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J. Immunol. 148:1992;1864-1870.
49. Novelli F., Di Pierro F., Francia di Celle P., Bertini S., Affaticati P., Garotta G., Forni G. Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J. Immunol. 152:1994;496-504.
50. Nunez G., Merino R., Grillot D., Gonzalez-Garcia M. Bcl-2 and Bcl-x: Regulatory switches for lymphoid death and survival. Immunol. Today. 15:1994;582-588.
51. Oberhaus S. M., Smith R. L., Clayton G. H., Dermody T. S., Tyler K. L. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J. Virol. 71:1997;2100-2106.
52. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
53. Pollak I. F., Lund R. D. The blood-brain barrier protects foreign antigens in the brain from immune attack. Exp. Neurol. 108:1990;114-121.
54. Rabizadeh S., LaCount D. J., Friesen P. D., Bredesen D. E. Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J. Neurochem. 61:1993;2318-2321.
55. Rocha G., Baines M. G. The immunology of the eye and its systemic interactions. Crit. Rev. Immunol. 12:1992;81-100.
56. Roizman B., Spear P. G., Kieff E. D. Herpes simplex viruses I and II: A biochemical definition. Perspect. Virol. 8:1972;129-169.
57. Sandberg K., Kemper P., Stadler A., Zhang J., Hobbs M. V., Whitton J. L., Campbell I. L. Altered tissue distribution of viral replication and T cells spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-α/β J. Immunol. 153:1994;220-231.
58. Schijns V. E. C., Claassen I. J. T., Vermeulen A. A., Horzinek M. C., Osterhaus A. D. M. E. Modulation of antiviral immune responses by exogenous cytokines: Effects of tumor necrosis factor-α, interleukin-1α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine. J. Gen. Virol. 75:1994;55-63.
59. Sloan D. J., Wood M. J., Charlton H. M. The immune response to intracerebral neural grafts. Trends Neurosci. 14:1991;341-346.
60. Streilein J. W. Anterior chamber-associated immune deviation: The privilege of immunity in the eye. Surv. Ophthalmol. 35:1990;67-73.
61. Streilein J. W. Immune privilege as the result of local tissue barriers and in immunosuppressive microenvironments. Curr. Opin. Immunol. 5:1993;428-432.
62. Tompsett E., Abi-Hanna D., Wakefield D. Immunological privilege in the eye. a review. Curr. Eye Res. 9:1990;1141-1145.
63. Tsunoda I., Kurtz C. I., Fujinami R. S. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology. 228:1997;338-393.
64. Tyor W. R., Glass J. D., Griffith J. W., Becker P. S., McArthur J. C., Bezman L., Griffin D. E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
65. Ubol S., Tucker P. C., Griffin D. E., Hardwick J. M. Neurovirulent strains of alphavirus induce apoptosis in bcl-2-expressing cells: Role of a single amino acid change in the E2 glycoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;5202-5206.
66. Whittum-Hudson J. A., Pepose J. S. Immunologic modulation of virus-induced pathology in a murine model of acute herpetic retinal necrosis. Invest. Ophthalmol. Vis. Sci. 28:1987;1541-1548.
67. Yamada T., Yamaoka S. G., Nakai M., Tsujimoto Y., Hatanaka M. The human T-cell leukemia virus type I tax protein induces apoptosis which is blocked by the bcl-2 protein. J. Virol. 68:1994;3374-3379.
68. Yin X. M., Oltval Z. N., Korsmeyer S. J. Bh1 and BH2 domains are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
69. Zauli G., Gibellini D., Milani D., Mazzoni M., Borgatti P., La Placa M., Capitani S. Human immunodeficiency virus type-1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:1993;4481-4485.
70. Zhong L. T., Sarafian T., Kane D. J., Charles A. C., Mah S. P., Edwards R. H., Bredesen D. H. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA. 90:1993;4533-4537.